Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...

A recombinant laminin matrix from Amsbio has played a key role in a new study from the Stanford University School of Medicine ...

Typically, bone marrow research relies heavily on animal models and oversimplified cell cultures in the laboratory. Now, researchers from the Department of Biomedicine at the University of Basel and ...

Natural killer (NK) cells are essential effectors of the innate immune system. These cells exhibit potent anti-tumor capabilities, making them appealing candidates for cancer immunotherapy. While ...

The Emulate Brain-Chip R1 integrates key FUJIFILM Cellular Dynamics iCell (R) products co-cultured with Emulate's proprietary induced Brain Microvascular Endothelial Cells (BMECs) to provide ...